Author

Martin Reck

German Center for Lung ResearchORCID 0000-0002-5336-9739Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pathology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Assay:protein structure· 1

Frequent Co-Authors

Carsten Heidel· 2 shared Christiane Kuempers· 2 shared Daniel Droemann· 2 shared Doerte Nitschkowski· 2 shared Jutta KirfeliD· 2 shared Sabine BohnetiD· 2 shared Soenke von Weihe· 2 shared Till OlchersiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Carsten Heidel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cells

Christiane Kuempers, Karina Stein, Doerte Nitschkowski, Tobias Jagomast, Carsten Heidel, Jutta Kirfel, Daniel Droemann, Sabine Bohnet, Micheal Schweigert, Martin Reck, Till Olchers, Soenke von Weihe, Ole Ammerpohl, Torsten Goldmann

bioRxiv · Jul 16, 2026 · PreprintPathology

Protein expression level of P2RY12 correlates with survival in Non-Small Cell Lung Cancer and exhibits diagnostic potential for Squamous Cell Carcinomas of the Lung

Christiane Kuempers, Hauke Roettger, Tobias Jagomast, Lukas Emken, Carsten Heidel, Finn‐Ole Paulsen, Tristan Tuecking, Jutta Kirfel, Daniel Droemann, Sabine Bohnet, Michael Schweigert, Martin Reck, Till Olchers, Soenke von Weihe, Volker Meidl, , Torsten Goldmann

bioRxiv · Jun 17, 2026 · PreprintPathology

Red blood cell-tumour cell interactions promote tumour cell progression

Thais Pereira‐Veiga, Celso Yáñez-Gómez, Aleksi Pekkarinen, Carmen Abuín, Christine Blechner, Miriam González-Conde, Christian Meß, Sabine Vidal‐y‐Sy, Ayham Moustafa, Bente Siebels, Ana Belén Dávila-Ibáñez, Pablo Cabezas‐Sainz, Maider Santos, Laura Sánchez, Joao Gorgulho, , Clotilde Costa

This study shows that red blood cells from cancer patients enhance tumour cell invasiveness and metastatic potential through gene and protein changes, suggesting PAK4 as a therapeutic target.

Journal of Experimental & Clinical Cancer Research · Apr 29, 2025Peer-reviewedCancer Biology